Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Martinez

Showing results (591-600 of 600) with videos related to

Pageof 60
Sort By:
You have reached the last page of results.This site can display upto 600 results.
Journal of Hepatology|October 18, 2023
Predicting survival in patients with 'non-high-risk' acute variceal bleeding receiving β-blockers+ligation to prevent re-bleedingLorenz Balcar, Mattias Mandorfer, Virginia Hernández-Gea, et al.
Human Molecular Genetics|February 2, 2013
A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia AJérôme Lane, Paul J McLaren, Lucy Dorrell, et al.
Nature|August 2, 2023
Africa-specific human genetic variation near CHD1L associates with HIV-1 loadPaul J McLaren, Immacolata Porreca, Gennaro Iaconis, et al.
Science Immunology|July 20, 2022
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNsPaul Bastard, Sara E Vazquez, Jamin Liu, et al.
Science (New York, N.Y.)|September 25, 2020
Autoantibodies against type I IFNs in patients with life-threatening COVID-19Paul Bastard, Lindsey B Rosen, Qian Zhang, et al.
Genome Medicine|April 5, 2023
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19Daniela Matuozzo, Estelle Talouarn, Astrid Marchal, et al.
Medrxiv : the Preprint Server for Health Sciences|November 3, 2022
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19Daniela Matuozzo, Estelle Talouarn, Astrid Marchal, et al.
Research Square|January 19, 2022
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodiesJeremy Manry, Paul Bastard, Adrian Gervais, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2022
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodiesJérémy Manry, Paul Bastard, Adrian Gervais, et al.
Science Immunology|August 20, 2021
Autoantibodies neutralizing type I IFNs are present in <b>~</b>4% of uninfected individuals over 70 years old and account for <b>~</b>20% of COVID-19 deathsPaul Bastard, Adrian Gervais, Tom Le Voyer, et al.
Pageof 60

Showing results (591-600 of 600) with videos related to

Sort By:
Pageof 60
You have reached the last page of results.This site can display upto 600 results.
Journal of Hepatology|October 18, 2023
Predicting survival in patients with 'non-high-risk' acute variceal bleeding receiving β-blockers+ligation to prevent re-bleedingLorenz Balcar, Mattias Mandorfer, Virginia Hernández-Gea, et al.
Human Molecular Genetics|February 2, 2013
A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia AJérôme Lane, Paul J McLaren, Lucy Dorrell, et al.
Nature|August 2, 2023
Africa-specific human genetic variation near CHD1L associates with HIV-1 loadPaul J McLaren, Immacolata Porreca, Gennaro Iaconis, et al.
Science Immunology|July 20, 2022
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNsPaul Bastard, Sara E Vazquez, Jamin Liu, et al.
Science (New York, N.Y.)|September 25, 2020
Autoantibodies against type I IFNs in patients with life-threatening COVID-19Paul Bastard, Lindsey B Rosen, Qian Zhang, et al.
Genome Medicine|April 5, 2023
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19Daniela Matuozzo, Estelle Talouarn, Astrid Marchal, et al.
Medrxiv : the Preprint Server for Health Sciences|November 3, 2022
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19Daniela Matuozzo, Estelle Talouarn, Astrid Marchal, et al.
Research Square|January 19, 2022
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodiesJeremy Manry, Paul Bastard, Adrian Gervais, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2022
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodiesJérémy Manry, Paul Bastard, Adrian Gervais, et al.
Science Immunology|August 20, 2021
Autoantibodies neutralizing type I IFNs are present in <b>~</b>4% of uninfected individuals over 70 years old and account for <b>~</b>20% of COVID-19 deathsPaul Bastard, Adrian Gervais, Tom Le Voyer, et al.
Pageof 60